Clinical trial
Irbesartan in Type 2 Diabetes
NCT00317915 · Steno Diabetes Center Copenhagen, Other · Completed
Key facts
| NCT number | NCT00317915 |
|---|---|
| Title | Irbesartan in Type 2 Diabetes |
| Official title | The Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) |
| Lead sponsor | Steno Diabetes Center Copenhagen, Other |
| Collaborators | Bristol-Myers Squibb Industry Sanofi-Synthelabo |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Microalbuminuria, Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan treatment |
| First posted | Apr 25, 2006 |
| Last update posted | Apr 25, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: